Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence

Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence

Katarina Kelin1, Alan JM Brnabic2, Richard Newton3, Ra&uacute;l I Escamilla4, Liang-Jen Chuo5, Malina Simu6, Wenyu Ye2, William Montgomery1, Jamie Karagianis7, Haya Ascher-Svanum81Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 2Intercontinental Information Sciences, Eli Lilly Austra...

Full description

Bibliographic Details
Main Authors:	Katarina Kelin, Alan JM Brnabic, Richard Newton, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-08-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/baseline-characteristics-and-initial-treatment-decisions-for-patients--a5022

Similar Items

Subjective Rationalities of Nonadherence to Treatment and Vaccination in Healthcare Decision-Making
by: Turja T, et al.
Published: (2024-04-01)

Refractory epilepsy and nonadherence to drug treatment
by: Oliver Henning, et al.
Published: (2019-12-01)

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
by: Haddad PM, et al.
Published: (2014-06-01)

Medication nonadherence among South American patients with schizophrenia
by: Caqueo-Urízar A, et al.
Published: (2017-10-01)

THE RISK FACTORS FOR EPILEPSY TREATMENT GAP AND NONADHERENCE TO ANTIEPILEPTIC DRUGS IN KILIFI, KENYA
by: Mbuba, C, et al.
Published: (2011)

Evaluation of nonadherence to treatment among patients with schizophrenia attending psychosocial care centers in the south region of Brazil
by: Camila Poletto Viveiros, et al.
Published: (2020-10-01)

Treatment nonadherence and neurocognitive impairment in bipolar disorder.
by: Martinez-Aran, A, et al.
Published: (2009)

Identification of primary care patients at risk of nonadherence to antidepressant treatment
by: Ann-Charlotte &Aring;kerblad, et al.
Published: (2009-01-01)

Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
by: Dilla T, et al.
Published: (2013-04-01)

Nonadherence to Multimodality Cancer Treatment Guidelines in the United States
by: Leila T. Tchelebi, MD, et al.
Published: (2022-09-01)

Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics
by: Bernardo M, et al.
Published: (2011-12-01)

Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand
by: Sirijit Suttajit, et al.
Published: (2010-09-01)

Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach.
by: Laurent Boyer, et al.
Published: (2012-01-01)

Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE BRAZIL Study
by: Elisa Oliveira Marsicano-Souza, et al.
Published: (2021-05-01)

Social determinants of nonadherence to tuberculosis treatment in Buenos Aires, Argentina
by: Maria Belen Herrero, et al.
Published: (2015-09-01)

Causes of nonadherence to treatment in people with myocardial infarction: Content analysis
by: Yaghoub Nadery, et al.
Published: (2021-01-01)

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
by: Novick D, et al.
Published: (2017-06-01)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
by: Xiaomei Peng, et al.
Published: (2011-01-01)

Nonadherence to treatment in lung transplant recipients: a matter of life and death
by: André Nathan Costa, et al.
Published: (2015-02-01)

Nonadherence to treatment protocol in published randomised controlled trials: a review
by: Dodd Susanna, et al.
Published: (2012-06-01)

Nonadherence to treatment in lung transplant recipients: a matter of life and death
by: André Nathan Costa, et al.
Published: (2015-02-01)

A perspective on nonadherence to drug therapy: psychological barriers and strategies to overcome nonadherence
by: Martin LR, et al.
Published: (2018-08-01)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
by: Sabine F. B. van der Horst, et al.
Published: (2023-07-01)

Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD
by: Foda HD, et al.
Published: (2017-01-01)

Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease
by: Shorouk Mohsen, et al.
Published: (2019-01-01)

Is there a nonadherent subtype of hypertensive patient? A latent class analysis approach
by: Ranak B Trivedi, et al.
Published: (2010-07-01)

Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross‐sectional multisite study
by: Ibinda, F, et al.
Published: (2017)

Intentional and unintentional medication nonadherence
by: Ng, Jamie Suat-Ling
Published: (2016)

Nonadherence to immunosuppression: challenges and solutions
by: Moreso F, et al.
Published: (2015-06-01)

Understanding and preventing nonadherence and treatment dropout in adolescents and young adults with anxiety and depressive disorders
by: Ruth C. Waumans, et al.
Published: (2023-11-01)

The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression
by: Juan Francisco Roy, et al.
Published: (2021-04-01)

Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
by: Patrick S Sullivan, et al.
Published: (2007-01-01)

The Role of Parents' Medication Beliefs, Religious Problem-Solving, and Risks for Treatment Nonadherence in Urban Families with Asthma
by: Sue K. Adams, et al.
Published: (2011-01-01)

Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
by: Zanatta JMM, et al.
Published: (2021-02-01)

When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review.
by: Leon Wreyford, et al.
Published: (2023-01-01)

Nonadherence to treatment recommendations is a factor contributing to the clinical failure of daptomycin: Cohort study in Brazil
by: Tathiana Silva de Souza Martins, et al.
Published: (2020-11-01)

Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study
by: Dulcinea Vega, et al.
Published: (2021-07-01)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
by: Xinhua&nbsp;S Ren, et al.
Published: (2009-09-01)

Posterior reversible encephalopathy syndrome due to nonadherence to antihypertensive treatment: A case report from Nepal
by: K.C. Priyanka, et al.
Published: (2024-01-01)

Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia.
by: Dina Bisara Lolong, et al.
Published: (2023-01-01)